Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer’s disease

Author:

Shahid Syed Salman12,Wen Qiuting12ORCID,Risacher Shannon L123ORCID,Farlow Martin R234,Unverzagt Frederick W25,Apostolova Liana G12346,Foroud Tatiana M236,Zetterberg Henrik78910ORCID,Blennow Kaj78,Saykin Andrew J12346,Wu Yu Chien123

Affiliation:

1. Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine , Indianapolis, IN , USA

2. Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine , Indianapolis, IN , USA

3. Stark Neuroscience Research Institute, Indiana University School of Medicine , Indianapolis, IN , USA

4. Department of Neurology, Indiana University School of Medicine , Indianapolis, IN , USA

5. Department of Psychiatry, Indiana University School of Medicine , Indianapolis, IN , USA

6. Department of Medical and Molecular Genetics, Indiana University School of Medicine , Indianapolis, IN , USA

7. Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg , Mölndal , Sweden

8. Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital , Mölndal , Sweden

9. Department of Neurodegenerative Disease, UCL Institute of Neurology , Queen Square, London , UK

10. UK Dementia Research Institute at UCL , London , UK

Abstract

Abstract Hippocampal subfields exhibit differential vulnerabilities to Alzheimer’s disease-associated pathology including abnormal accumulation of amyloid-β deposition and neurofibrillary tangles. These pathological processes extensively impact on the structural and functional interconnectivities of the subfields and may explain the association between hippocampal dysfunction and cognitive deficits. In this study, we investigated the degree of alterations in the microstructure of hippocampal subfields across the clinical continuum of Alzheimer’s disease. We applied a grey matter-specific multi-compartment diffusion model (Cortical-Neurite orientation dispersion and density imaging) to understand the differential effects of Alzheimer’s disease pathology on the hippocampal subfield microstructure. A total of 119 participants were included in this cross-sectional study. Participants were stratified into three categories, cognitively normal (n = 47), mild cognitive impairment (n = 52), and Alzheimer’s disease (n = 19). Diffusion MRI, plasma biomarkers and neuropsychological test scores were used to determine the association between the microstructural integrity and Alzheimer’s disease-associated molecular indicators and cognition. For Alzheimer’s disease-related plasma biomarkers, we studied amyloid-β, total tau and neurofilament light; for Alzheimer’s disease-related neuropsychological tests, we included the Trail Making Test, Rey Auditory Verbal Learning Test, Digit Span and Montreal Cognitive Assessment. Comparisons between cognitively normal subjects and those with mild cognitive impairment showed significant microstructural alterations in the hippocampal cornu ammonis (CA) 4 and dentate gyrus region, whereas CA 1–3 was the most sensitive region for the later stages in the Alzheimer’s disease clinical continuum. Among imaging metrics for microstructures, the volume fraction of isotropic diffusion for interstitial free water demonstrated the largest effect size in between-group comparisons. Regarding the plasma biomarkers, neurofilament light appeared to be the most sensitive biomarker for associations with microstructural imaging findings in CA4-dentate gyrus. CA 1–3 was the subfield which had stronger correlations between cognitive performance and microstructural metrics. Particularly, poor performance on the Rey Auditory Verbal Learning Test and Montreal Cognitive Assessment was associated with decreased intracellular volume fraction. Overall, our findings support the value of tissue-specific microstructural imaging for providing pathologically relevant information manifesting in the plasma biomarkers and neuropsychological outcomes across various stages of Alzheimer’s disease.

Funder

National Institutes of Health

Department of Radiology and Imaging Sciences at IUSM

Advanced Imaging Research Technology Development

Swedish Research Council

European Research Council

Swedish State Support for Clinical Research

Alzheimer Drug Discovery Foundation

Alzheimer's Disease Strategic Fund

Alzheimer's Association

Olav Thon Foundation

Erling-Persson Family Foundation

Erling-Persson Family Foundation, Stiftelsen för Gamla Tjänarinnor, Hjärnfonden, Sweden

European Union's Horizon 2020 research

Marie Skłodowska-Curie

UK Dementia Research Institute

Swedish Alzheimer Foundation

Hjärnfonden

Sweden

ALF-agreement

European Union Joint Program for Neurodegenerative Disorders

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3